Neoteryx is focused on delivering simple, quantitative, and automatable microsampling solutions for biological samples which improve welfare, reduce costs, and enable convenient sample collection anywhere, anytime, by anyone.
Recent Posts by Neoteryx:
by Neoteryx, on April 19,2022
April 2022 — Trajan Scientific and Medical, (Trajan, ASX:TRJ) partnered with researchers at The University of Queensland (UQ) to develop a portable skin microbiopsy device that takes tissue samples smaller …
Read Storyby Neoteryx, on February 14,2022
February 2022 — Device company Neoteryx, which is now part of the Trajan Scientific and Medical family, announces the release of a new tech note for research customers that use …
Read Storyby Neoteryx, on January 11,2022
January 2022 – As announced by Trajan Group Holdings Limited (ASX: TRJ) in early January from their headquarters in Australia, the company has acquired microsampling leader Neoteryx LLC. As reported …
Read Storyby Neoteryx, on December 1,2021
December 2021 — US-based medical device company Neoteryx announces its user-friendly at-home specimen collection kit for children in support of labs and research customers that conduct pediatric studies, clinical trials …
Read Storyby Neoteryx, on November 16,2021
November 2021 — The Mitra® microsampling device from US-based Neoteryx has been registered in Brazil as a Class 1 in vitro diagnostic (IVD) medical device by ANVISA, the Agência Nacional …
Read StoryThe latest product releases, company news and microsampling industry updates from Neoteryx.
If you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com
Fact Sheet & FAQs
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.